Edgar Jaimes

[American Society of Onconephrology @onconephsociety]

High Dose Methotrexate-Induced Acute Kidney Injury: Incidence, Risk Factors, and Recovery ⁦@KIReports⁩ https://t.co/U4vlPXv4Gn

[American Society of Onconephrology @onconephsociety]

Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: Emphasizing the need for a consensus approach https://t.co/wfMBksXj2a

[Aisha Shaikh @aishaikh]

Thank you @WCM_HMPOCUS for organizing such an amazing POCUS training program. Can’t wait to utilize (& refine) my POCUS skills to improve patient care. Special shout out to @TanpingWong, Greg Mints, @nilamjsoni @KoraAbhi 👏🏽👏🏽👏🏽

[Aisha Shaikh @aishaikh]

📌 “Immunotherapies and renal injury” published in Current Opinion in Toxicology

https://t.co/DfgaTrfiwj

📌 Tweetorial

🔸 Basic principle of immunotherapy

🔸Impact of immune checkpoint inhibitors on kidney function

1/

[AJP Renal @AJPRenal]

Fig 8- Expression of nicotinic acetylcholine receptors (nAChRs) in normal mice.
By: Edgar A. Jaimes, et al.
🔓https://t.co/CpeWUolHzN
#ImageOfTheWeek #Nicotin #Smoking @MSKCancerCenter @umiamimedicine @ejaimes63

[Memorial Sloan Kettering Nephrology @MSK_Neph]

Great talk by Dr. Chris Blosser @blosserc On “Management of kidney transplant recipients with cancer”
at @MSK_Neph Onconeph Conference
-Incidence of cancer & outcomes among KTRs has not changed over 30-years
-ICI Rx can cause rejection in up to 50% patients

[GrepMed @grepmeded]

Hypercalcemia Workup - Differential Diagnosis Algorithm by Dr. Aisha Shaikh @aishaikh

https://t.co/ppkVyG3XoF

#FOAMed #MedEd #nephpearls

[Aisha Shaikh @aishaikh]

Often hear “I have never found an ⬆️PTHrP in work-up for hypercalcemia” Here is another one: PTHrP = 83 pmol/L
🔑 PTHrP hypercalcemia in malignancy:
- hypercalcemia less responsive to bisphosphonates
- associated with shorter survival
#OncoNephrology

[Aisha Shaikh @aishaikh]

Thank you for inviting me to give this talk. @GlomCon Fellows: what an amazing group and a special shout to @Koubar_Sahar and @SubhashPaudel1 for their excellent case presentations

[Memorial Sloan Kettering Cancer Center @MSKCancerCenter]

Congratulations! 🎊 👏

[Memorial Sloan Kettering Nephrology @MSK_Neph]

Dr. Irina Barash discussing Autosomal Dominant Polycystic Kidney Disease at Cornell Nephrology grand rounds @WeillCornell

- ADPKD US diagnostic criteria
- Predictors of GFR loss
- Indications for Jynarque & how to
monitor treatment response

[Aisha Shaikh @aishaikh]

Excellent talk on “Applications of Mass Spectrometry for Amyloidosis Diagnosis and Monitoring” by Dr. Jessica Chapman at the @MSK_Neph Onco-nephrology Conference

Why is Immunohistochemistry not ideal for amyloid subtype identification

[Marius Lange @MariusLange8]

Finally published in @naturemethods: CellRank for directed #SingleCell fate mapping, our take on studying cellular dynamics using RNA velocity. Fantastic collab between labs of @dana_peer @sloan_kettering and @fabian_theis @HelmholtzMunich, read at https://t.co/AlgyUvI1PP. 1/17

[Memorial Sloan Kettering Nephrology @MSK_Neph]

A very warm welcome to Dr. Belen Nunez who will be joining @MSK_Neph for Onco-nephrology fellowship in 2022.
#Onconephrology

[Phil Kantoff @DrPhilKantoff]

Failures teach you everything. You learn nothing from success. https://t.co/Sk17TjrtQe

[THINKFLOYD 🗣 @THINKFL0YD]

How’s that whole #CreepyUncleJoe narrative working out for .@realDonaldTrump again?

As always, here’s Trump in his own words #CreepyTrump #MAGA2020